Ground breaking study helps patients with synthetic form of magic mushrooms in caring for treatment-resistant depression.
Twenty two countries were involved in the research - making this the largest study of its kind.
Historical note: In the 1950s–1970s, studies conducted with LSD—which acts on the same brain receptors as psilocybin—reported strong results in treating substance use disorders, including alcohol and heroin addiction. But when LSD became illegal in 1968, funding for this work gradually dried up.
A single dose of a synthetic version of the mind-altering component of magic mushrooms, psilocybin, improved depression in people with a treatment-resistant form of the disease, a new study found. CNN's Dr. Sanjay Gupta reports.
The latest research adds more potential for natural remedies for the treatment of diseases. Previously this year, Johns Hopkins research the use of psychedelics in the treatment of Alzheimer’s disease.
Johns Hopkins Scientists Give Psychedelics the Serious Treatment
In a major boost to the reviving field, Johns Hopkins’s Center for Psychedelic and Consciousness Research is exploring the use of psychedelics—primarily psilocybin—for problems ranging from smoking addiction to anorexia and Alzheimer’s disease.
Medical Cannabis Doctors and Clinics
Get Your MMJ Card Today!
Ask about Same-Day Medical Marijuana Card Evaluations
Medical Marijuana Cards - New & Renewal
Cannabis Friendly Doctors and Clinics
HIPAA-compliant secure safe affordable
SSL-encryption!
Fast affordable effective!
Ask about telemedicine!
Ask about Veterans discounts!
100% money-back guarantee: if a patient does not qualify for a medical cannabis recommendation, the patient will not be charged.
Comments